 |
|
|
|
 |
|
|
| Article 1 to 9 out of 9 concerning The Wellcome Trust
|
-
Novel method to reveal drug targets
(02/25/2008)
Interactions between proteins studied on a global scale
Wellcome Trust Sanger Institute scientists have developed a new large-scale method to identify the interactions between proteins that are a major target for therapeutic intervention. The novel method can identify the weak, short-lived interactions ...
-
Novacta receives £3.5 million strategic translation award from the Wellcome trust ot target C. difficile infections
(01/16/2008)
Novacta Biosystems, a UK-based anti-infective therapeutics company, announced that the Wellcome Trust, the UK's largest medical research charity, has awarded it £3.5 million as part of the Trust's Strategic Translational Award programme. Novacta ...
-
Galapagos and the University of Bristol enter drug discovery collaboration
(02/16/2007)
Galapagos NV and the University of Bristol announced a new drug discovery collaboration in the field of cancer research. Galapagos' service division BioFocus DPI will provide lead optimization services for a University of Bristol research program ...
-
New antibacterials being developed to tackle MRSA superbug
(01/16/2007)
Prolysis receives a £3.48 million Seeding Drug Discovery award from the Wellcome Trust
A novel antibacterial medicine that kills Methicillin-resistant Staphylococcus aureus (MRSA) is being developed under a new scheme launched by the Wellcome Trust. The Seeding Drug Discovery initiative is aimed at catalysing the development of new ...
-
Scientists unlock more secrets of HIV and SARS
(05/16/2006)
UK scientists have cracked one of the key biological processes used by viruses such as HIV and SARS when they replicate according to a paper published in the journal Nature. Viruses are able to interfere with the host cell processes that our bodies ...
-
BTG Licenses Alzheimer's Compounds To Senexis And Co-Invests £1 Million With The Wellcome Trust
(02/07/2006)
BTG plc and Senexis Limited announced that BTG has exclusively licensed its novel inhibitors of amyloid-induced toxicity and neuroinflammation to Senexis. These compounds may be useful in the treatment of Alzheimer's Disease and other amyloid-based ...
-
Mass Analysis of DNA from Whole Populations
(04/22/2005)
Nobel Prize winner Dr Sydney Brenner has devised a new method for obtaining sequence information from thousands of genomes simultaneously. Current technologies can only analyse one genome at a time. This method, to be developed by a new company ...
-
Microscience's Phase II Typhoid Vaccine Programme in South East Aisia was Awarded £1.95 Million
(03/24/2005)
Microscience PLC announced that it has been awarded a Wellcome Trust Strategic Translation Award (STA) of £1.95 million to advance the clinical development of Microscience's drinkable typhoid vaccine programme. This is the largest single STA ever ...
-
Breakthrough for Schizophrenia sufferers
(06/10/2004)
Scientists funded by the UK's largest biomedical research charity, The Wellcome Trust, have developed a drink that enhances the effectiveness of medication given to treat psychiatric illnesses such as mania and schizophrenia.
A team of researchers from the Department of Psychiatry at Oxford University have found that they can achieve this, and probably reduce problematic side effects from traditional treatments, by supplementing medication with a specially designed ...
|
|
|
|
|
Top
